Prinz, J C <br/><br/>
Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.  [electronic resource] 

 -  Journal of the European Academy of Dermatology and Venereology : JEADV  May 2011 
 - 559-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1468-3083 
<br/><br/><label>Standard No.: </label>10.1111/j.1468-3083.2010.03838.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Psoriatic--drug therapy<br/>Dermatologic Agents--therapeutic use<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Male<br/>Middle Aged<br/>Psoriasis--drug therapy<br/>Quality of Life<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Severity of Illness Index<br/>Treatment Outcome